Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 9/20 | 1.00 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.82 |
| ▸ | ADORA1 | P30542 | 6/20 | 0.82 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.82 |
| ▸ | THPO | P40225 | 1/20 | 0.82 |
| ▸ | TSHR | P16473 | 1/20 | 0.82 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N6-Benzyladenosine SCHEMBL13966412 | 1.00 | ADORA3 (1.00) | ADORA3SLC29A1TP53TDP1ADORA2A | |
| N6-Benzyladenosine SCHEMBL219438 | 1.00 | ADORA3 (1.00) | ADORA3SLC29A1TP53TDP1ADORA2A | |
| N6-Benzyladenosine SCHEMBL20419317 | 1.00 | ADORA3 (1.00) | ADORA3SLC29A1TP53TDP1ADORA2A | |
| N6-Benzyladenosine SCHEMBL15614834 | 1.00 | ADORA3 (1.00) | ADORA3SLC29A1TP53TDP1ADORA2A | |
| N6-Benzyladenosine SCHEMBL472635 | 1.00 | ADORA3 (1.00) | ADORA3SLC29A1TP53TDP1ADORA2A | |
| N6-Benzyladenosine SCHEMBL23982413 | 1.00 | ADORA3 (1.00) | ADORA3SLC29A1TP53TDP1ADORA2A | |
| N6-Benzyladenosine SCHEMBL20419282 | 1.00 | ADORA3 (1.00) | ADORA3SLC29A1TP53TDP1ADORA2A | |
| N6-Benzyladenosine SCHEMBL3283829 | 1.00 | ADORA3 (1.00) | ADORA3SLC29A1TP53TDP1ADORA2A | |
| N6-Benzyladenosine SCHEMBL219439 | 1.00 | ADORA3 (1.00) | ADORA3SLC29A1TP53TDP1ADORA2A | |
| N6-Benzyladenosine SCHEMBL30230333 | 1.00 | ADORA3 (1.00) | ADORA3SLC29A1TP53TDP1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2412716-A1 | Partial and full agonists of A1 adenosine receptors | CV THERAPEUTICS, INC. (US) | 2012-02-01 | — | — | EP | disclosed |